LEVEL OF URIC ACID IN BLOOD SERUM OF NEW PULMONARY TUBERCULOSIS PATIENTS WITH MULTIPLE DRUG RESISTANCE

LEVEL OF URIC ACID IN BLOOD SERUM OF NEW PULMONARY TUBERCULOSIS PATIENTS WITH MULTIPLE DRUG RESISTANCE

The level of uric acid in blood serum was investigated in 134 new patients suffering from multiple drug resistant pulmonary tuberculosis (78 men and 56 women). The tests were performed by admission to hospital and then repeated in 1, 2, 3, 4, 5, 6, 7 and 8 months of treatment. Prior to chemotherapy...

Full description

Bibliographic Details
Main Authors:	R. Yu. Аbdullaev, O. G. Komissarova, E. S. Chumakova, V. S. Odinet
Format:	Article
Language:	Russian
Published:	NEW TERRA Publishing House 2017-04-01
Series:	Tuberkulez i Bolezni Lëgkih
Subjects:	tuberculosis uric acid pyrazinamide chemotherapy
Online Access:	https://www.tibl-journal.com/jour/article/view/993

Similar Items

The study of cross-resistance of MTB to certain anti-tuberculosis drugs among tuberculosis patients in Tomsk Region
by: P. N. Golubchikov, et al.
Published: (2020-01-01)

A comparative study on the adverse effects of two anti-tuberculosis drugs regimen in initial two-month treatment period
by: Begum Lutfun Nahar, A.K.M. Mosharrof Hossain, M. Monirul Islam and Dipti Rani Saha
Published: (2006-12-01)

A multiple genome analysis of Mycobacterium tuberculosis reveals specific novel genes and mutations associated with pyrazinamide resistance
by: Patricia Sheen, et al.
Published: (2017-10-01)

Genetic Diversity and Drug Susceptibility Profiles of Multidrug-Resistant Tuberculosis Strains in Southeast China
by: Lin S, et al.
Published: (2021-09-01)

Intestinal barrier function and serum concentrations of rifampin, isoniazid and pyrazinamide in patients with pulmonary tuberculosis
by: Mônica C. Façanha, et al.

Evaluation of disease patterns, treatment and prognosis of tuberculosis in AIDS patient
by: Angela Naomi Atomiya, et al.

Evaluation of disease patterns, treatment and prognosis of tuberculosis in AIDS patient
by: Atomiya Angela Naomi, et al.
Published: (2002-01-01)

pncA Gene Mutations Associated with Pyrazinamide Resistance in Drug-Resistant Tuberculosis, South Africa and Georgia
by: Salim Allana, et al.
Published: (2017-03-01)

PYRAZINAMIDE/PYRAZINOIC ACID RESISTANCE IN MYCOBACTERIUM TUBERCULOSIS: RECENT FINDINGS AND IMPLICATIONS FOR IMPROVING THE TREATMENT OF TUBERCULOSIS
by: R. M. Anthony, et al.
Published: (2018-12-01)

The molecular basis of resistance to isoniazid, rifampin, and pyrazinamide in <it>Mycobacterium tuberculosis</it>
by: Parsons Linda M, et al.
Published: (2001-04-01)

Characterization of pyrazinamide resistance in consecutive multidrug-resistant mycobacterium tuberculosis isolates in sweden between 2003 and 2015
by: Mikael Mansjo, et al.
Published: (2017-01-01)

\"Caracterização molecular de mutações no gene pncA de isolados clínicos de Mycobacterium tuberculosis de origem brasileira\"
by: Patricia Barco
Published: (2004)

\"Caracterização molecular de mutações no gene pncA de isolados clínicos de Mycobacterium tuberculosis de origem brasileira\"
by: Barco, Patricia
Published: (2004)

Resistance To First-Line Antituberculosis Drugs And Prevalence Of pncA Mutations In Clinical Isolates Of Mycobacterium tuberculosis From Zunyi, Guizhou Province Of China
by: Cao Z, et al.
Published: (2019-09-01)

Value of pyrazinamide for composition of new treatment regimens for multidrug-resistant Mycobacterium tuberculosis in China
by: Hui Xia, et al.
Published: (2020-01-01)

Frequency and characteristics of adverse events caused by anti-tuberculosis drugs in pulmonary tuberculosis patients with diabetes myelitis
by: O. G. Komissarova, et al.
Published: (2020-03-01)

Performance of Wayne assay for detection of pyrazinamide resistance in Mycobacterium tuberculosis: a meta-analysis study
by: M.J. Nasiri, et al.
Published: (2021-07-01)

The Application of the Therapeutic Drug Monitoring (TDM) of First and Second-Line Drugs for Multidrug-Resistant Tuberculosis Patients (MDRTB)
by: Anun Chaikoolvatana, et al.
Published: (2017-03-01)

Detection of pyrazinamide heteroresistance in Mycobacterium tuberculosis
by: Mikaela Glader, et al.
Published: (2015-01-01)

The Prospective Synergy of Antitubercular Drugs With NAD Biosynthesis Inhibitors
by: Kyle H. Rohde, et al.
Published: (2021-01-01)

Mutations in Efflux Pump Rv1258c (Tap) Cause Resistance to Pyrazinamide, Isoniazid, and Streptomycin in M. tuberculosis
by: Jiayun Liu, et al.
Published: (2019-02-01)

Colorimetric methods for rapid determination of pyrazinamide resistance
by: Ahmet Ugur Akbal, et al.
Published: (2020-01-01)

A novel inexpensive electrochemical sensor for pyrazinoic acid as a potential tool for the identification of pyrazinamide-resistant Mycobacterium tuberculosis
by: Daniel Rueda, et al.
Published: (2018-01-01)

Pyrazinamide Resistance and Mutation Patterns Among Multidrug-Resistant Mycobacterium tuberculosis from Henan Province
by: Shi J, et al.
Published: (2020-08-01)

The preformulation investigation of a combination anti-tuberculosis dosage form
by: Ebrahim, Salma
Published: (2018)

Assessment of adherence to antituberculosis drug regimen among patients receiving isoniazid, rifampin and pyrazinamide: Kerman, Iran
by: Seyyed Mojtaba Sohrevardi, et al.
Published: (2019-07-01)

Novel Mutations in pncA Gene of Pyrazinamide Resistant Clinical Isolates of Mycobacterium tuberculosis
by: Manijeh Kahbazi, et al.
Published: (2018-04-01)

The impact of inclusion, dose and duration of pyrazinamide (PZA) on efficacy and safety outcomes in tuberculosis: systematic review and meta-analysis protocol
by: James D. Millard, et al.
Published: (2019-12-01)

The majority of patients with multidrug-resistant tuberculosis in Sub-Saharan Africa present a concomitant resistance to pyrazinamide
by: Géraldine Daneau, et al.
Published: (2016-01-01)

Characterization of pncA Mutations and Prediction of PZA Resistance in Mycobacterium tuberculosis Clinical Isolates From Chongqing, China
by: Kun Li, et al.
Published: (2021-01-01)

A 34-Year-Old Obese Woman with Rash, Finger Swelling and Fever
by: Na Huo, et al.
Published: (2017-06-01)

Significance of Serum Uric Acid in Children with Pulmonary Arterial Hypertension
by: Şuteu Carmen Corina, et al.
Published: (2016-06-01)

Serum uric acid levels and uric acid/creatinine ratios: affordable biomarkers for predicting chronic obstructive pulmonary disease severity and exacerbations
by: Hesham A AbdelHalim, et al.
Published: (2018-01-01)

Hepatotoxic reactions during treatment of newly diagnosed patients with pulmonary multiple drug resistant tuberculosis
by: R. Yu. Аbdullаev, et al.
Published: (2019-08-01)

Resistência primária e adquirida à pirazinamida em pacientes com tuberculose pulmonar atendidos em um hospital de referência no Recife Primary and acquired pyrazinamide resistance in patients with pulmonary tuberculosis treated at a referral hospital in the city of Recife, Brazil
by: Liany Barros Ribeiro, et al.
Published: (2012-12-01)

Serum uric acid concentration and blood pressure level in hemodialysis patients
by: Viroj Wiwanitkit
Published: (2016-04-01)

EFFICIENCY OF CHEMOTHERAPY WITH BEDAQUILINE IN DRUG RESISTANT PULMONARY TUBERCULOSIS PATIENTS
by: A. M. Tikhonov, et al.
Published: (2018-03-01)

Effect of Carum carvi, a herbal bioenhancer on pharmacokinetics of antitubercular drugs: A study in healthy human volunteers
by: Naiyma Choudhary, et al.
Published: (2014-01-01)

The Relationship Between the Multiple Sclerosis and Endogenous Antioxidan Serum Uric Acid
by: Fatma Candan, et al.
Published: (2007-12-01)

The antimicrobial and antimycobacterial activity of plants used for the treatment of respiratory ailments in Southern Africa and the isolation of anacardic acid from ozoroa paniculosa.
by: Seaman, Tracy
Published: (2006)

Cannot write session to /tmp/vufind_sessions/sess_kv4rn5ovbn9in6hqb8kcksgs0t